CFTR and cystic fibrosis: Using nasal and bronchial epithelial cultures from individual CF patients for drug testing through in vitro assays, such as electrophysiological measurements of CFTR activity and assessments of ion and fluid movement in organoid cultures, allows for the prediction of patient-specific responses [22].